Exact Sciences Co. (NASDAQ:EXAS) Stock Holdings Trimmed by Westpac Banking Corp
Westpac Banking Corp reduced its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 10.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 142,455 shares of the medical research company’s stock after selling 16,512 shares during the quarter. […]